Dolby Laboratories, Inc. (DLB) Q3 2025 Earnings Call Transcript
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants Kevin J. Yeaman - President, CEO & Director Peter L.
Fiscal Year: October - September
Dolby Laboratories, Inc. (DLB), listed on the NYSE, has a market capitalization of $. As of Aug 19, 2025, the stock is trading at $73.69 per share, offering investors a clear view of its current market value. Dolby Laboratories, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 27.23, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Dolby Laboratories, Inc. also offers a dividend yield of 1.79%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Dolby Laboratories, Inc. (DLB) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Dolby Laboratories, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Dolby Laboratories, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Dolby Laboratories, Inc. is 16.15, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Dolby Laboratories, Inc. (DLB) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Dolby Laboratories, Inc. (DLB) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Dolby Laboratories, Inc. (DLB) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Dolby Laboratories, Inc.. To access the full SS Score, consider upgrading your subscription.
Dolby Laboratories, Inc. is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 27.23. Investors should compare these metrics with industry peers to gauge whether Dolby Laboratories, Inc. is outperforming or underperforming within its sector.
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants Kevin J. Yeaman - President, CEO & Director Peter L.
SAN FRANCISCO , July 31, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2025. "We had solid results in Q3 and ...
Dolby Laboratories, Inc. is now attractively valued, with a forward P/E below 20x and a 1.77% dividend yield, making it a compelling buy. Earnings have improved significantly, and the company's licens...
SAN FRANCISCO , July 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the third quarter (Q3) fiscal yea...
SAN FRANCISCO , May 12, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that Kevin Yeaman, President and CEO, will host a fireside chat at the William Blair 45th Annual Growth...
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2025 Earnings Conference Call May 1, 2025 5:00 PM ET Company Participants Peter Goldmacher - Vice President, Investor Relations Kevin Yeaman - Chief Executive O...
SAN FRANCISCO , May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter w...
SAN FRANCISCO , April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal y...
AMC has also selected Dolby Vision as its HDR offering of choice SAN FRANCISCO and LEAWOOD, Kan. , March 31, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertain...
This monthly article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitati...
Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 ...
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2025 Earnings Conference Call January 29, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - President, CEO & Director Robert Park - ...
SAN FRANCISCO , Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start fo...
SAN FRANCISCO , Jan. 13, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the first quarter (Q1) fiscal ye...
Dolby will spotlight its latest innovations in automotive, including an exclusive first look at the latest vehicles to support Dolby Atmos and the world's first car to support Dolby Vision along with ...
Dolby Laboratories reported strong Q4 and FY 2024 results, with significant improvements in revenue, operating income, and free cash flow, boosting the stock by over 15%. Management highlights growth ...
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2024 Earnings Conference Call November 19, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - CEO Robert Park - CFO Conference Call P...
SAN FRANCISCO , Nov. 19, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the fourth quarter and fiscal year 2024. "We are pleased with the ...
SAN FRANCISCO , Oct. 10, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment, will release financial results for the fourth quarter (Q4) and full year of fis...
FanDuel, ITV, Las Vegas Sands, NASCAR, NFL, and others are leveraging these latest solutions to increase engagement while improving the streaming and iGaming experiences of their audiences AMSTERDAM ,...
SAN FRANCISCO , Sept. 5, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that Kevin Yeaman, President and CEO, will host a fireside chat at the Goldman Sachs Communacopia and ...
After an impressive rally, the market is almost back to record highs, but it's always and forever a market of stocks, not a stock market. Dozens of companies are trading at 52-week lows. Some are valu...
SAN FRANCISCO , Aug. 13, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that Robert Park, Chief Financial Officer, will host a fireside chat at the Rosenblatt Technology Summ...
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2024 Results Conference Call August 7, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - CEO Robert Park - CFO Conference Call Parti...
SAN FRANCISCO , Aug. 7, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2024. "Our third quarter results were i...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
Year | FCF Estimate | % | # Analysts |
---|---|---|---|
2025 | 375.81M | 26.43% | Est @26.4% |
2026 | 454.38M | 20.91% | Analyst x1 |
2027 | 502.53M | 10.60% | Analyst x1 |
2028 | 524.32M | 4.34% | Est @4.3% |
2029 | 544.11M | 3.78% | Est @3.8% |
2030 | 561.34M | 3.17% | Est @3.2% |
2031 | 577.67M | 2.91% | Est @2.9% |
2032 | 593.44M | 2.73% | Est @2.7% |
2033 | 608.89M | 2.60% | Est @2.6% |
2034 | 623.16M | 2.35% | Est @2.3% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
Year | FCF | Discount Factor | PV of Future FCF |
---|---|---|---|
2023A | 336.74M | 1.00 | 336.74M |
2024A | 297.25M | 1.00 | 297.25M |
2025E | 375.81M | 1.09 | 345.52M |
2026E | 454.38M | 1.18 | 384.08M |
2027E | 502.53M | 1.29 | 390.54M |
2028E | 524.32M | 1.40 | 374.63M |
2029E | 544.11M | 1.52 | 357.44M |
2030E | 561.34M | 1.66 | 339.03M |
2031E | 577.67M | 1.80 | 320.77M |
2032E | 593.44M | 1.96 | 302.96M |
2033E | 608.89M | 2.13 | 285.79M |
2034E | 623.16M | 2.32 | 268.92M |
Terminal | 10.19B | 2.32 | 4.40B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.